Diagnostic Medical Systems : Imaging2027 : un retour aux sources porteur de croissance
Depuis 2022, DMS Group, leader français de la radiologie conventionnelle, a rationalisé son portefeuille en recentrant son activité sur l’imagerie médicale et lancé une stratégie ambitieuse à horizon 2027 (#Imaging2027). L’objectif est d’atteindre 70 M€ de revenus (vs 46 M€ en 2024) et de générer une marge d’EBITDA de 14% (vs 6% en 2024). Le modèle hybride insufflé par le nouveau management (OEM et marque propre), soutenu par une offre différenciante (Platinum, Stratos, Onyx, !M1, ADAM), ouvre un cycle de croissance rentable. Nous initions le titre à Surperformance avec un objectif de cours de 2.1 €.DIAGNOSTIC MEDICAL SYSTEMS SA, (formerly known as DMS), is a France-based company, which together with its subsidiaries, designs, produces and markets medical imagery devices dedicated to conventional and digital radiology as well as bone densitometry. The Company manufactures a range of products for bone densitometry examination, including the ultrasound imaging system UBIS 5000, Challenger Envision, Stratos dR and Stratos. In the radiology sector, its products include Baccara dRF 43, EOL, Platinum and Da Vinci solutions, among others. In addition, it offers such products as scanners, transcranial Doppler, and Giotto Image mammography system. The Company operates several direct subsidiaries, AXS Medical, Apelem SAS, which manufactures radiology equipment, Medilink SARL, which produces Doppler and bone densitometry devices, Apelem SA, based in Spain, Alpha MOS based in France and one indirect subsidiary, SA Apelem and one indirect affiliated company, Spectrap.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.